Genelux (GNLX) Selling, General & Administrative (2022 - 2026)
Genelux's Selling, General & Administrative was $3.39 million in Q1 2026, up 8.8% from $3.12 million a year earlier but down 9.9% from the prior quarter.
Powered by 
Analysis
Genelux (GNLX) Selling, General & Administrative (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Genelux's Selling, General & Administrative was $13.65 million through Mar 31, 2026, up 16.5% year-over-year; for FY2025, it was $13.37 million, up 5.2% from FY2024.
- Selling, General & Administrative has now increased for three consecutive years, with a three-year compound annual growth rate of 38.8% (FY2022 to FY2025).
- In earlier years, Selling, General & Administrative was $12.71 million in FY2024 (+9.8%), $11.57 million in FY2023 (+131.2%) and $5 million in FY2022.
- Quarterly Selling, General & Administrative has moved between $694,000 (Q4 2022) and $4.11 million (Q1 2024) over five years.
- Compared with a year earlier, Selling, General & Administrative has increased for four straight quarters, with growth averaging 9.3% over the last eight quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q4 2023 (growth of 309.4%); the worst was Q1 2025 (a decline of 24.2%).
- Per Business Quant data, GNLX's Selling, General & Administrative in the three quarters before Q1 2026 was $3.77 million (Q4 2025), $3.45 million (Q3 2025) and $3.03 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Genelux | 88.78 Mn | 27.06 Mn | - | 3.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3.39 Mn |
| Dec 31, 2025 | 3.77 Mn |
| Sep 30, 2025 | 3.45 Mn |
| Jun 30, 2025 | 3.03 Mn |
| Mar 31, 2025 | 3.12 Mn |
| Dec 31, 2024 | 3.23 Mn |
| Sep 30, 2024 | 2.89 Mn |
| Jun 30, 2024 | 2.48 Mn |
| Mar 31, 2024 | 4.11 Mn |
| Dec 31, 2023 | 2.84 Mn |
| Sep 30, 2023 | 2.49 Mn |
| Jun 30, 2023 | 2.45 Mn |
| Mar 31, 2023 | 3.79 Mn |
| Dec 31, 2022 | 694,000.00 |
| Sep 30, 2022 | 2.24 Mn |
API Access
Genelux Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=GNLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "GNLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=GNLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();